Novus Scientific AB
USPTO PatentsView assignee record - 14 granted patents across 9 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Novus ranks #20,171 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 9 technology areas.
- #20,171
- of 49,997 US assignees by volume
- Top 50%
- by Innovation Score (35.3/100)
- 17.2
- avg claims per patent
- -25%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R20171 · Foreign Corporation #20,171 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 14 grants
- MID-PACK #20,171/49,997
- PHOTO-FINISH Nota
- CPC-NARROW A61F · 9 areas
- INNOV-THIN 35.3/100
- CLAIMS-RICH 17.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -25% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Nota, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Novus’s 35.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Novus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Novus Scientific AB · this assignee
Novus Scientific AB · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Novus's Innovation Score is 35.3/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Novus?
Each dot is one of Novus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novus’s own 17.2 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Novus's grants concentrate
Novus Scientific AB is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (5 grants) versus a trough of 1 in 2015. By volume, Novus sits between Nota, Inc. and Nutcracker Therapeutics, Inc..
Novus's three-year grant acceleration
Novus Scientific AB shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Novus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nota
Nota, Inc.
14 patents
- Novasolix
Novasolix, Inc.
14 patents
- Novatek IP
Novatek IP, LLC
14 patents
- Novmetapharma
Novmetapharma Co., Ltd
14 patents
- NSI International
NSI International, Inc.
14 patents
- NTT Data Services
NTT Data Services, LLC
14 patents
- Nurix Therapeutics
Nurix Therapeutics, Inc.
14 patents
- Nutcracker Therap…
Nutcracker Therapeutics, Inc.
14 patents
- Novus Scientific… ◀
Novus Scientific AB
14 patents
What this shows Novus holds 14 patents at rank #20,148, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Novus
By rank, the assignees closest to #20,148 in granted patent volume.
- Nota, Inc. #20,144 · 14 patents
- Novasolix, Inc. #20,145 · 14 patents
- Novatek IP, LLC #20,146 · 14 patents
- Novmetapharma Co., Ltd #20,147 · 14 patents
- NSI International, Inc. #20,149 · 14 patents
- NTT Data Services, LLC #20,150 · 14 patents
- Nurix Therapeutics, Inc. #20,151 · 14 patents
- Nutcracker Therapeutics, Inc. #20,152 · 14 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Novus's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Novus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 7.1% |
| 2017 | 5 | 35.7% |
| 2018 | 1 | 7.1% |
| 2019 | 1 | 7.1% |
| 2020 | 3 | 21.4% |
| 2022 | 3 | 21.4% |
Which technologies does Novus Scientific AB patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Novus Scientific AB's patent record in context - here's where to go next.
- Novus Scientific AB's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #20,171 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Novus Scientific AB against Nota, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.